# Amyloidosis Foundation

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/amyloidosis-foundation/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 69 |
| Citations | 252,504 |
| City | Clarkston |
| Country | US |
| Description | Amyloidosis Foundation is a research organisation in Clarkston, US. OpenAlex records 1,439 works and 252,504 citations for it. 655 researchers list it as their most recent affiliation. |
| Homepage | http://www.amyloidosis.org/ |
| OpenAlex ID | https://openalex.org/I4210109810 |
| Region | Michigan |
| Researchers | 655 |
| ROR ID | https://ror.org/01pfv2y33 |
| Type | nonprofit |
| Works | 1,439 |

## University papers

- [Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy](https://scholariq.org/papers/tafamidis-treatment-for-patients-with-transthyretin-amyloid-cardiomyopathy/)
- [Expert Consensus Recommendations for the Suspicion and Diagnosis of Transthyretin Cardiac Amyloidosis](https://scholariq.org/papers/expert-consensus-recommendations-for-the-suspicion-and-diagnosis-of/)
- [Genotype and Phenotype of Transthyretin Cardiac Amyloidosis](https://scholariq.org/papers/genotype-and-phenotype-of-transthyretin-cardiac-amyloidosis/)
- [Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy](https://scholariq.org/papers/vutrisiran-in-patients-with-transthyretin-amyloidosis-with-cardiomyopathy/)
- [Screening for Transthyretin Amyloid Cardiomyopathy in Everyday Practice](https://scholariq.org/papers/screening-for-transthyretin-amyloid-cardiomyopathy-in-everyday-practice/)
- [Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis](https://scholariq.org/papers/patisiran-treatment-in-patients-with-transthyretin-cardiac-amyloidosis/)
- [Pharmacogenomics of ABC transporters and its role in cancer chemotherapy](https://scholariq.org/papers/pharmacogenomics-of-abc-transporters-and-its-role-in-cancer-chemotherapy/)

## University top topics

Showing 8 of 25.

- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)
- [Alzheimer's disease research and treatments](https://scholariq.org/topics/alzheimer-s-disease-research-and-treatments/)
- [Dermatological and Skeletal Disorders](https://scholariq.org/topics/dermatological-and-skeletal-disorders/)
- [Pericarditis and Cardiac Tamponade](https://scholariq.org/topics/pericarditis-and-cardiac-tamponade/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.